Clinical trial
Brazilian COVID-19 Registry for Clinical Presentation of Individuals With COVID-19: a National, Multicentre, Prospective Observational Study (SARS-Brazil)
NCT04479488 is registered in ClinicalTrials.gov with Hospital Israelita Albert Einstein as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Brazilian COVID-19 Registry for Clinical Presentation of Individuals With COVID-19: a National, Multicentre, Prospective Observational Study (SARS-Brazil)
- Lead sponsor
- Hospital Israelita Albert Einstein
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 27, 2020
- Completion date
- December 30, 2022
- Enrollment
- 1,587 (actual)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.
covid19, sars-cov infection